Chicago Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Chicago Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-986,958	Closed	-$21.4M	–	32
2017 Q2	$21.4M	Buy	+986,958	New	+$17.9M	4.78%	9

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Chicago Capital Management's AMRI Position: Q3 2017 in Review

Chicago Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 986,958 shares — an estimated $21.4M sold.

Chicago Capital Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $21.4M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Chicago Capital Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Chicago Capital Management sold 986,958 Albany Molecular Research Inc shares in Q3 2017, an estimated $21.4M.
Chicago Capital Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
Chicago Capital Management's Albany Molecular Research Inc position peaked at $21.4M in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Chicago Capital Management's 13F filing for Q3 2017, filed 11 Oct 2017.